Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Medicine, DNA methylation, Cancer research, Methylation, Gene silencing, and Biology.
Effects of KEAP1 Silencing on NRF2 and NOTCH Pathways in SCLC Cell Lines
Think “HER2” different: integrative diagnostic approaches for HER2-low breast cancer
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
Design and experimental validation of OPERA_MET-A panel for deep methylation analysis by next generation sequencing
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study
Potential Prognostic Role of SPARC Methylation in Non-Small-Cell Lung Cancer
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer
Methylation Density Pattern of KEAP1 Gene in Lung Cancer Cell Lines Detected by Quantitative Methylation Specific PCR and Pyrosequencing
Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors
Automated Workflow for Somatic and Germline Next Generation Sequencing Analysis in Routine Clinical Cancer Diagnostics
P2.14-32 Epigenetic Silencing of SPARC in NSCLCs
The 2015 World Health Organization Classification of lung tumors: new entities since the 2004 Classification.
PubMed 2018cited by 46position: last
Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation
Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma
Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients
Abstract 2397: Epigenetic silencing in clear renal cell carcinoma: <i>KEAP1</i> promoter hypermethylation
Abstract 4734: miR-9-5p expression in breast cancer correlates with hormone receptor status and affects patients survival
Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients
Endoscopic treatment of primary benign central airway tumors: Results from a large consecutive case series and decision making flow chart to address bronchoscopic excision
A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas
Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids
Endoscopic management of benign tracheobronchial tumors: Ten-year experience from a large, single center case series
Primary Neuroendocrine Tumors of the Thymus: A Multicenter Experience of 35 Patients
Frequency and clinical correlations of epidermal growth factor receptor (EGFR) mutations in a large cohort of Italian non-small cell lung cancer (NSCLC) patients (pts) within the EGFR FASTnet program.